ArticleAmerican health & drug benefits2016

Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma.

Lisa A RaedlerPubMed ↗Full text ↗

No numbers read from the abstract.